Clinical and Molecular Characteristics of SLC16A2 (MCT8) Mutations in Three Families with the Allan-Herndon-Dudley Syndrome.
about
Clinical and Molecular Characteristics of SLC16A2 (MCT8) Mutations in Three Families with the Allan-Herndon-Dudley Syndrome.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh-hant
name
Clinical and Molecular Charact ...... Allan-Herndon-Dudley Syndrome.
@en
Clinical and Molecular Characteristics of SLC16A2
@nl
type
label
Clinical and Molecular Charact ...... Allan-Herndon-Dudley Syndrome.
@en
Clinical and Molecular Characteristics of SLC16A2
@nl
prefLabel
Clinical and Molecular Charact ...... Allan-Herndon-Dudley Syndrome.
@en
Clinical and Molecular Characteristics of SLC16A2
@nl
P2093
P2860
P356
P1433
P1476
Clinical and Molecular Charact ...... Allan-Herndon-Dudley Syndrome
@en
P2093
Elena Freri
Francesca Novara
Margherita Estienne
Orsetta Zuffardi
Paolo Reho
Stefan Groeneweg
Theo J Visser
W Edward Visser
P2860
P304
P356
10.1002/HUMU.23140
P577
2017-01-05T00:00:00Z